Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary

作者: Nadeem R. Abu-Rustum , Antonella Restivo , Joseph Ivy , Robert Soslow , Paul Sabbatini

DOI: 10.1016/J.YGYNO.2006.01.050

关键词:

摘要: Abstract Objective. To describe the incidence of retroperitoneal pelvic or paraaortic lymph node metastasis in patients with primary and recurrent ovarian granulosa cell tumors. Methods. At Memorial Sloan-Kettering Cancer Center, we conducted a retrospective chart review all tumors managed as inpatients from January 1991 to July 2005. The initial date diagnosis ranged 1971 Results. We identified 68 median age 49 years (mean, 47.5 years; range, 19–78 years). Sixty-four (94%) had adult type 4 (6%) juvenile Fifty-three (78%) their surgery at another institution 55 (81%) were incompletely surgically staged due absence and/or aortic dissection. Patients assigned an International Federation Gynecology Obstetrics (FIGO) stage that included IA, 39; IC, 15; IIB, 3; IIC, IIIC, 1. In 7 patients, original was not assigned. Only 16 (24%) sampling 13 (19%) also restaging performed shortly following diagnosis; however, these cases, nodes negative for metastasis. number removed 10 11.6 nodes; 0–36 nodes). 6 0–19 Nine 15 (60%) initially our compared 53 (7.5%) who elsewhere ( P Thirty-four during study, 31 (91%) tumor, 3 histology. Thirty-three 34 recurred operation. Original "clinical" FIGO 8; 1; available. disease-free interval first recurrence 63 months (mean,69.4 months; 4–170 months). First sites pelvis, 24/34 (70%); pelvis abdomen, (9%); retroperitoneum only, 2 (6%); retroperitoneum, pelvis/abdomen/retroperitoneum, 1(3%); abdomen 1 (3%); bone, (3%). Conclusions. Complete surgical staging approximately 1/5 women tumors; those staged, no nodal identified. Clinical IA disease most common recurred, 15% recurrences appear involve retroperitoneum.

参考文章(7)
Brigitte E. Miller, Beth A. Barron, Jim Y. Wan, James E. Delmore, Elvio G. Silva, David M. Gershenson, Prognostic factors in adult granulosa cell tumor of the ovary Cancer. ,vol. 79, pp. 1951- 1955 ,(1997) , 10.1002/(SICI)1097-0142(19970515)79:10<1951::AID-CNCR16>3.0.CO;2-U
Jubilee Brown, Hyun S. Shvartsman, Michael T. Deavers, Lois M. Ramondetta, Thomas W. Burke, Mark F. Munsell, David M. Gershenson, The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors Gynecologic Oncology. ,vol. 97, pp. 489- 496 ,(2005) , 10.1016/J.YGYNO.2005.01.011
Gavin C.E. Stuart, Lesa M. Dawson, Update on granulosa cell tumours of the ovary. Current Opinion in Obstetrics & Gynecology. ,vol. 15, pp. 33- 37 ,(2003) , 10.1097/00001703-200302000-00005
Susan Tinsley Schumer, Stephen A. Cannistra, Granulosa Cell Tumor of the Ovary Journal of Clinical Oncology. ,vol. 21, pp. 1180- 1189 ,(2003) , 10.1200/JCO.2003.10.019
Alexander Mustea, Peter Klare, Jalid Sehouli, Werner Lichtenegger, Dirk Elling, Mantred Dietel, Frank S Drescher, Margit Nehmzow, Wolfgang Friedmann, Wolfgang Kühn, Firu Opri, Granulosa cell tumor of the ovary: 10 years follow-up data of 65 patients. Anticancer Research. ,vol. 24, pp. 1223- 1229 ,(2004)
R Mercan, K Yüce, A Ayhan, Z S Tuncer, R Tuncer, Granulosa cell tumor of the ovary. A clinicopathological evaluation of 60 cases European Journal of Gynaecological Oncology. ,vol. 15, pp. 320- 324 ,(1994)